Delivery Order SPE2DB22D1106-SPE2DB25FEKB0

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Wegovy 2.4 mg/0.75 ml pens, a medication used to treat obesity. The contract has a ceiling value of $2,457.00 and an ultimate completion date of April 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery...
This is a $12,285.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5 mg/0.5 ml Wegovy pens, a medication used in the treatment of obesity. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 1 mg/0.5 mL pens, a medication used to treat obesity. The contract has a ceiling value of $2,726.36 and a period of performance through April 2025. It is a firm-fixed-price contract and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 1 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract has a ceiling value of $7,600.89 and a period of performance through April 2025. The contract is a firm fixed-price delivery order, which indicates it is part of a larger Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,582.96, is for the supply of Wegovy 0.5 mg/0.5 mL pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 0.25 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract has a ceiling value of $1,638.00 and a period of performance through April 18, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Wegovy 0.5 mg/0.5 mL pens, a medication used for weight management. The contract has a ceiling value of $2,457.00 and runs through February 11, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 2.4 mg/0.75 ml pens. The contract has a ceiling value of $5,363.46 and a period of performance through April 11, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 2.4 mg/0.75 ml pens. The contract has a ceiling value of $5,951.40 and a period of performance through April 11, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 2.4 mg/0.75 ml pen (0.75 ml) and has a ceiling value of $23,839.46. It is a firm fixed price contract with an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEKB0
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Wegovy 1 mg/0.5 ml pens, a medication used to treat obesity. The order has a ceiling value of $47,730.50 and a period of performance through April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for federal agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026. The contract does not have a set-aside designation, indicating open competition.

Generated 7/22/25, 10:06 AM